SM
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Complete response of a metastatic microsatellite-stable gastric cancer after neoadjuvant chemoimmunotherapy : should we still operate ? A case report and review of the literature | Frontiers in oncology |  | 2024 | 62 | 64 | ||
| Cancer de l’œsophage : standards et innovations du traitement multidisciplinaire | Revue médicale suisse | | 2023 | 110 | 233 | ||
| Changes of health-related quality of life 6 months after high-risk oncological upper gastrointestinal and hepatobiliary surgery: a single-centre prospective observational study (ChangeQol Study) | BMJ open | | 2023 | 164 | 196 | ||
| Laparoscopic for advanced gastric cancer—minimally invasive for maximal results? | Translational gastroenterology and hepatology | | 2022 | 442 | 107 | ||
| Implementation and validation of a competency assessment tool for laparoscopic cholecystectomy | Surgical endoscopy and other interventional techniques | | 2022 | 174 | 136 | ||
| Severity of oEsophageal Anastomotic Leak in patients after oesophagectomy: the SEAL score | British journal of surgery | | 2022 | 172 | 185 | ||
| Assessment of predictors of early postoperative complications after primary robotically assisted Roux-en-Y gastric bypass: a multicenter, retrospective cohort study | Surgical endoscopy | | 2022 | 182 | 117 | ||
| Therapieoptionen beim oligometastasierten Magenkarzinom | Der Chirurg | | 2021 | 350 | 229 | ||
| Blood-based multi-cancer detection using a novel variant calling assay (DEEPGENTM): early clinical results | Cancers | | 2021 | 261 | 95 | ||
| Anastomotic leak following oesophagectomy: research priorities from an international Delphi consensus study | British journal of surgery |  | 2021 | 324 | 0 | ||
| Impact of nonalcoholic steatohepatitis on the outcome of patients undergoing roux-en-y gastric bypass surgery: a propensity score-matched analysis | Obesity Surgery | | 2021 | 229 | 105 | ||
| Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study | European journal of surgical oncology | | 2021 | 307 | 0 | ||
| Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma - the phase III "PREVENT"- (FLOT9) trial of the AIO /CAOGI /ACO | BMC cancer | | 2021 | 374 | 216 | ||
| Esophageal cancer surgery: review of complications and their management | Annals of the New York Academy of Sciences | | 2020 | 242 | 1 | ||
| S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und ösophagogastralen Übergangs | Der Chirurg | | 2020 | 218 | 1 | ||
| Quand référer un patient en vue d'un traitement chirurgical de l'obésité | Revue médicale suisse | | 2020 | 417 | 262 | ||
| Cancer de l'œsophage et de la jonction oesogastrique: prise en charge et traitement multidisciplinaire | Revue médicale suisse | | 2020 | 498 | 393 | ||
| RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV | BMC Cancer | | 2020 | 236 | 146 | ||
| Fit-for-discharge criteria after esophagectomy: an international expert delphi consensus | Diseases of the Esophagus | | 2020 | 235 | 1 | ||
| Current surgical treatment standards for esophageal and esophagogastric junction cancer | Annals of the New York Academy of Sciences | | 2020 | 212 | 1 | ||
| Incidence and grading of complications after gastrectomy for cancer using the GASTRODATA registry: a european retrospective observational study | Annals of Surgery | | 2020 | 213 | 1 | ||
| Development and Validation of a Predictive Model for Internal Hernia after Roux-en-Y Gastric Bypass in a Multicentric Retrospective Cohort: The Swirl, Weight Excess Loss, Liquid Score | Annals of Surgery | | 2020 | 523 | 2 | ||
| International Variation in Surgical Practices in Units Performing Oesophagectomy for Oesophageal Cancer: A Unit Survey from the Oesophago-Gastric Anastomosis Audit (OGAA) | World journal of surgery | | 2019 | 438 | 13 | ||
| Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial | The Lancet | | 2019 | 411 | 1 | ||
| Minimal length of proximal resection margin in adenocarcinoma of the esophagogastric junction: a systematic review of the literature | Updates in Surgery | | 2019 | 354 | 2 | ||
| S3-Leitlinie Magenkarzinom – Diagnostik und Therapie der Adenokarzinome des Magens und des ösophagogastralen Übergangs | Zeitschrift für Gastroenterologie | | 2019 | 404 | 0 | ||
| Delay in initiation adjuvant S-1 monotherapy for gastric cancer: important prognostic factor | Translational Gastroenterology and Hepatology | | 2019 | 321 | 182 | ||
| The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma | European Journal of Cancer | | 2019 | 281 | 1 | ||
| S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus | Zeitschrift für Gastroenterologie | | 2019 | 339 | 345 | ||
| International consensus on a complications list after gastrectomy for cancer | Gastric cancer | | 2019 | 335 | 0 | ||
| Laparoscopic Surgery for Gastric Cancer: The European Point of View | Journal of Oncology | | 2019 | 334 | 166 | ||
| Neoadjuvant chemoradiation for patients with advanced oesophageal cancer - which response grading system best impacts prognostic discrimination? | Histopathology | | 2019 | 435 | 1 | ||
| The role of surgery in advanced disease for esophageal and junctional cancer | Best Practice & Research: Clinical Gastroenterology | | 2018 | 347 | 1 | ||
| Cancer de l'estomac : prise en charge et traitement multidisciplinaire | Revue médicale suisse | | 2018 | 554 | 900 | ||
| Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801) | European journal of cancer | | 2018 | 321 | 0 | ||
| Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation | Annals of the New York Academy of Sciences | | 2018 | 360 | 0 | ||
| Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review | Critical reviews in oncology/hematology | | 2018 | 329 | 0 | ||
| Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACO | Pleura and Peritoneum | | 2018 | 382 | 239 | ||
| Chirurgische Strategie bei Frühkarzinomen des Ösophagus | Der Chirurg | | 2018 | 356 | 0 | ||
| Multimodal treatment in locally advanced gastric cancer | Updates in Surgery | | 2018 | 350 | 1 | ||
| Die Fremdkörperingestion – eine seltene Ursache persistierender, unklarer abdomineller Schmerzen | Deutsche Medizinische Wochenschrift | | 2018 | 349 | 0 | ||
| Cancer of the gastroesophageal junction: a diagnosis, classification, and management review | Annals of the New York Academy of Sciences | | 2018 | 354 | 0 | ||
| Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival | Gastric cancer | | 2017 | 134 | 125 | ||
| Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study | European journal of surgical oncology | | 2017 | 357 | 0 | ||
| Gastric cancer treatment in the world: Germany | Translational Gastroenterology and Hepatology | | 2017 | 643 | 1 | ||
| Therapeutisches Vorgehen beim oligometastasierten Magen- und Ösophaguskarzinom | Der Chirurg | | 2017 | 389 | 0 | ||
| Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2-Gastrectomy | World journal of surgery | | 2017 | 155 | 0 | ||
| Current and future treatment options for esophageal cancer in the elderly | Expert opinion on pharmacotherapy | | 2017 | 400 | 0 | ||
| Preoperative staging of nodal status in gastric cancer | Translational gastroenterology and hepatology | | 2017 | 738 | 0 | ||
| Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial | JAMA oncology | | 2017 | 207 | 0 | ||
| The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction - a phase III trial of the German AIO/CAO-V/CAOGI | BMC cancer | | 2017 | 422 | 174 | ||
| Obstipation bei Patienten mit nicht-heilbarer Krebserkrankung: Empfehlungen der S3-Leitlinie Palliativmedizin | Deutsche medizinische Wochenschrift | | 2016 | 338 | 0 | ||
| Follow-up after gastrectomy for cancer: the Charter Scaligero Consensus Conference | Gastric cancer | | 2016 | 218 | 162 | ||
| Resektion beim fortgeschrittenen Adenokarzinom des Magens und des Ösophagus : Erweiterung der Indikation | Der Chirurg | | 2016 | 304 | 0 | ||
| Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma | Oncoimmunology | | 2016 | 157 | 138 | ||
| Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial | Lancet. Oncology | | 2016 | 386 | 0 | ||
| Description and analysis of clinical pathways for oesophago-gastric adenocarcinoma, in 10 European countries (the EURECCA upper gastro intestinal group - European Registration of Cancer Care) | European journal of surgical oncology | | 2016 | 187 | 0 | ||
| Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy? | Gastric cancer | | 2016 | 165 | 102 |
